Cite
APA Citation
Kumthekar, P., Lassman, A. B., Lin, N., Grimm, S., Gradishar, W., Pentsova, E., Jeyapalan, S., Groves, M., Melisko, M., & Raizer, J. (n.d.). lPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY. Neuro-oncology advances, 1, i6. http://access.bl.uk/ark:/81055/vdc_100117173713.0x000004